EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Critical Prognostic and Predictive Factors in Colorectal Liver Metastasis: A Thorough Analysis of Existing Literature and Future Outlook

Paul Pasca iD, Flaviu Ionut Faur, Cosmin Burta, Dan Brebu, Carmen Neamtu iD, Vlad Braicu, Ciprian Duta, Ioana Adelina Faur, Razvan Danau, Amadeus Dobrescu iD, Marius Murariu iD

Journal of Clinical Medicine · 24.06.2026 · 15 (13) · 4907

DOI: 10.3390/jcm15134907 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.06.2026. Verfasst von Paul Pasca und 10 weiteren Autor:innen. Beteiligte Einrichtung: IInd Surgery Clinic, Timisoara Emergency County Hospital, 300723 Timisoara, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) prognosis, particularly in liver metastasis (CRLM), is influenced by histopathological and molecular factors.

Methods

A narrative analysis of the specialized literature was conducted using databases such as PubMed, MEDLINE, Scopus, and Embase. The review focused on original articles published between 2005 and 2025.

Results

Lymph node involvement is a critical prognostic factor, with lymph node-positive CRC correlating with increased risk of liver metastasis and significantly reduced survival rates. Poorly differentiated tumors (G3) exhibit a higher likelihood of metastasis, including liver involvement, and are associated with worse clinical outcomes. Vascular emboli and perineural invasion are indicative of hematogenous spread and higher metastatic potential, leading to poorer survival outcomes. Genetic mutations, such as KRAS, NRAS, and BRAF, are associated with therapy resistance, complicating treatment and highlighting the importance of personalized approaches. MSI-H and HER2 amplification further affect treatment response, with MSI-H tumors showing a favorable response to immunotherapy, while HER2-positive CRCs may benefit from targeted therapies. Tumor budding, high levels of which predict poor survival, is another key histopathological feature associated with aggressive metastatic behavior. Systemic inflammatory markers, such as the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and C-Reactive Protein-to-Albumin Ratio (CAR), offer prognostic insights into CRLM patient survival.

Conclusions

Histopathological features, molecular alterations, and immune microenvironment factors significantly impact the prognosis of CRC with liver metastasis. The integration of molecular profiling, immunotherapy, and targeted therapies offers promise for improving treatment outcomes. Personalized treatment strategies, incorporating these factors, are essential for overcoming therapy resistance and improving survival in CRLM patients.

Schlagwörter

Stichwörter der Autor:innen

BRAF mutationKRAS mutationNRAS mutationdesmoplastic growth pattern (dHGP)inflammatory markersmicrosatellite instability (MSI)tumor budding

Autor:innen und Institutionen

  • IInd Surgery Clinic, Timisoara Emergency County Hospital, 300723 Timisoara, Romania.
  • X Department of General Surgery, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
  • Doctoral School of Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Multidisciplinary Doctoral School, "Vasile Goldiș" Western University of Arad, 310025 Arad, Romania.
  • Ist Clinic of General Surgery, Arad County Emergency Clinical Hospital, 310158 Arad, Romania.
  • Department of General Surgery, Faculty of Medicine, "Vasile Goldiș" Western University of Arad, 310025 Arad, Romania.

ORCID-Profile: Paul Pasca, Carmen Neamtu, Amadeus Dobrescu, Marius Murariu

Förderung

  • Victor Babeș University of Medicine and Pharmacy Timișoara

Zitieren

APA

Pasca, P., Faur, F. I., Burta, C., Brebu, D., Neamtu, C., Braicu, V., Duta, C., Faur, I. A., Danau, R., Dobrescu, A., & Murariu, M. (2026). Critical Prognostic and Predictive Factors in Colorectal Liver Metastasis: A Thorough Analysis of Existing Literature and Future Outlook. Journal of Clinical Medicine, 15(13), 4907. https://doi.org/10.3390/jcm15134907

Vancouver

Pasca P, Faur FI, Burta C, Brebu D, Neamtu C, Braicu V, et al. Critical Prognostic and Predictive Factors in Colorectal Liver Metastasis: A Thorough Analysis of Existing Literature and Future Outlook. Journal of Clinical Medicine. 2026;15(13):4907. doi:10.3390/jcm15134907

BibTeX
@article{Pasca2026,
  author = {Pasca, Paul and Faur, Flaviu Ionut and Burta, Cosmin and Brebu, Dan and Neamtu, Carmen and Braicu, Vlad and Duta, Ciprian and Faur, Ioana Adelina and Danau, Razvan and Dobrescu, Amadeus and Murariu, Marius},
  title = {Critical Prognostic and Predictive Factors in Colorectal Liver Metastasis: A Thorough Analysis of Existing Literature and Future Outlook},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {13},
  pages = {4907},
  doi = {10.3390/jcm15134907}
}
Kostenlos starten →